Novartis AG is 46.1x more valuable than Centessa Pharmaceuticals plc by market capitalization ($283.13 B vs $6.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNTA | NVS |
|---|---|---|
| Market cap | $6.14 B | $283.13 B |
| US-listed rank | #1247 | #47 |
| Revenue (latest FY) | $15.00M | - |
| Net income (latest FY) | -$197.53M | - |
| Net margin | -1316.9% | - |
| SEC filings | 579 | 947 |
Novartis AG is 46.1x more valuable than Centessa Pharmaceuticals plc by market capitalization ($283.13 B vs $6.14 B).
Full pages: Centessa Pharmaceuticals plc and Novartis AG, or browse the full rankings.